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Abstract 
Introduction: There is evidence that intermittent hypoxic exposure (IHE) may 
improve high altitude (HA) performance. In this study the effects of short-term IHE 
via voluntary apnoea training on HA-related symptoms including acute mountain 
sickness (AMS) were examined for the first time.  
Methods: Forty healthy adults were randomised to a self-administered apnoea 
training (n=19) or to a control group (n=21 no apnoea training) prior to ascent to an 
altitude of 5100m in the Himalayas over 14 days. The apnoea training was conducted 
at sea level and consisted of five breath holds per day in week one, seven in week 
two, followed by 10 per day from weeks 3-6 and until HA exposure. Arterial oxygen 
saturation (SpO2), heart rate, sleep quality (Insomnia Severity Index, ISI), rating of 
perceived exertion (RPE), blood pressure and Lake Louise Scores were measured at 
sea level (in the UK) and at HA at 1400m, 2700m, 3400-3700m, 4050-4200m, 
4800m and 5100-5200m.  Anxiety (GAD-7) scores were examined at sea level, 
1400m and at 5100-5200m 
Results: Apnoea training led to a significant improvement in the mean longest breath-
hold times from baseline (80.42±32.49 [median 87.00] seconds) to the end of week 
six (107.02±43.65 [113.00] seconds) respectively (p=0.009). There was no significant 
difference in the prevalence of AMS  (8/19=42.1% vs 11/21=52.4%; RR 0.80; 95% 
CI 0.41- 1.57: p=0.80) or in  GAD-7, ISI and RPE, SpO2, heart rate or blood pressure 
among the apnoea versus control groups respectively at HA.  
Conclusions: Apnoea training does not lessen HA-related symptoms in healthy adults 
travelling up to 5200m. Larger studies using more challenging apnoea protocols and 
to higher altitudes should be considered.  
Key words: High altitude, acute mountain sickness, apnoea training, anxiety, sleep, 
perceived exertion 
Introduction 
The recent improvements in infrastructure and access have led to significantly 
increasing numbers of persons travelling to high altitude (HA) than that of only a 
decade ago. HA-related symptoms including anxiety, insomnia and acute mountain 
sickness (AMS) are some of the commonest obstacles to success. AMS can rapidly 
worsen and lead to the development of HA cerebral oedema (HACE) and even death 
if it is unrecognised and not treated (Bartsch and Swenson 2013; Boos et al., 2018). 
HA-related hypoxia can also cause HA pulmonary oedema (HAPE), which is a non-
cardiogenic form of pulmonary oedema resulting from excessive hypoxic pulmonary 
vasoconstriction, which can also be fatal if not recognised and treated promptly 
(Bartsch and Swenson 2013). Unfortunately, despite intense research into the field, 
there are no reliable sea level predictors to identify individuals who are at a 
particularly high risk of developing AMS and its complications among a general 
population of otherwise healthy adults (Bartsch and Swenson 2013; Lawrence and 
Reid 2016; Masuet-Aumatell et al., 2017). 
Consequently, there has been an increasing focus not only on methods to try to identify 
individuals at increased risk of HAPE and AMS, but to pre-emptively mitigate their 
risk ‘prophylactically”. There is emerging, yet inconsistent, evidence to suggest that 
intermittent hypoxic exposure (IHE) can improve exercise performance and induce a 
degree of pre-acclimatisation (acclimation) that is associated with a reduction in the 
risk of AMS development and its severity (Dehnert et al., 2014; Fulco et al., 2013; 
Lizamore and Hamlin 2017; Molano Franco et al., 2019; Muza 2007; Wille et al., 
2012). These studies have used either altitude chambers or low FiO2 breathing 
(hypoxicators) to replicate the hypoxia of genuine terrestrial HA. Both methods are 
expensive and logistically challenging to perform, thereby limiting their widespread 
utility. The mechanisms to explain their benefit appear to be multiple and are still 
poorly understood. Those cited include increased erythropoiesis, angiogenesis and 
release of circulating stem cells, reducing oxidative stress and systemic inflammation, 
improved autonomic and mitochondrial function, chemosensitivity to hypoxia and 
aerobic performance (Casas et al., 2000; Gangwar et al., 2019; Povea et al., 2005; 
Viscor et al., 2018). Its benefits appear to be heavily influenced by the population 
studied, the mode, frequency and intensity of the hypoxic stimulus as well exercise 
components (Hamlin et al., 2018; Viscor et al., 2018). 
Voluntary breath holding (apnoea training), is another method of reproducing short-
lived IHE that has been used successfully for >25 years in free divers to enhance 
their performance (Bain et al., 2018). It has the obvious advantage over chamber-
based IHE in that there is no financial cost and it can be easily conducted in an 
individual’s own time. There is published data to suggest its positive effects on both 
aerobic and anaerobic exercise performance (Lemaitre et al., 2010) .   However, its 
impact on HA-related symptoms and performance has not been explored. Whilst the 
hypoxic period is far shorter with apnoeic training compared with conventional IHE 
it has been shown to induce a variety of physiological changes that could be 
potentially utilised to the benefit of HA acclimation. These include increased splenic 
volumes and contraction, increased circulating haematocrit and haemoglobin 
concentrations to potentially improve arterial oxygen content (Schagatay et al., 2001; 
Schagatay et al., 2005).  Other published mechanisms include increased chemo-
responsiveness, cerebral blood flow and the bradycardic response to apnoea (Bain et 
al., 2018). Together these factors may act to improve hypoxic resilience and lessen 
myocardial oxygen consumption whilst maintaining cerebral oxygenation which may 
be of translational benefit for HA acclimation (Costalat et al., 2014; Schagatay et al., 
2001).   Additional potential benefits include improved mindfulness and ventilatory 
control that may improve mood, anxiety and sleep quality (Cho et al., 2016; 
Lemaitre et al., 2010). It has been demonstrated that apnoeic duration and the 
magnitude of associated bradycardia are linked to a lower risk AMS supporting the 
potential translational impact of apnoea training to reduce HA-related illness (Austin 
and Sleigh 1995; Holmstrom et al., 2019). 
In this study we aimed to investigate for the first time the effects of apnoea training 
on HA related symptoms. We hypothesised that apnoea training offers a simple 
method of personal acclimation that leads to improved performance at HA and a 
reduction in the burden of AMS. 
Population and Design 
This was a prospective intention-to-treat observational study of 42 healthy adult 
male (n=30) and female (n=12) British military service volunteers who were due to 
take part in RAF 100 Ex Himalayan Venture 18, to the Himalayas in September 
2018.  They were all low altitude dwellers without previous breath hold training 
experience. The population consisted of two trekking teams (TT) in the Khumbu 
valley region of Nepal undertaking an identical ascent and one Alpine Team (AT). 
The AT followed a marginally different ascent profile but along a similar altitude 
and commencing in the Rolwaling Valley. The subjects were assessed at baseline 
(sea level [SL]), 1400m (day-1), 2700m (day-2 for TT and day-3 for AT), 3400-
3700m (day-3 for TT and day-4 for AT), 4050-4200m (day-5), 4800-4900m (day-7 
for AT and day-8 for TT). Rest days were scheduled where there was an altitude gain 
of ≥1000m, hence days-3 and 6 for the TT and days-6 and 8 for the AT. Thereafter, 
the sleep altitudes ranged from 4000- 4996 m on days 9-14 before a further ascent to 
5100-5200m in both groups on day 14.  None of the participants had been exposed to 
simulated or terrestrial HA in the preceding six weeks prior to inclusion. 
The primary study outcome measure was the development of AMS. Secondary 
outcome measures of interest were the comparative differences in heart rate, blood 
pressure, anxiety-related symptoms, sleep quality, peripheral arterial oxygen 
saturations (SpO2) and rating of perceived exertion (RPE).  
All participants were engaged in regular physical activity and had passed their 
Service Specific fitness tests and were fully fit for military duty.  A modified version 
of the Centre of Aviation Medicine (RAF Henlow) health questionnaire was used for 
the health screening of the participants prior to their inclusion.    
Randomisation and Apnoea Protocol 
The population of research volunteers were randomised to one to one of two research 
groups – a control group and an apnoea group.  
The apnoea protocol was conducted at SL and consisted of five breath holds per day 
in week one, seven in week two, followed by 10 per day from weeks 3-6 and at least 
until their departure to HA. This protocol  was designed following a previous study 
at HA (Mellor et al., 2017) and its demonstration of an  induction in splenic 
contraction in a previous sea level apnoea study  (Schagatay et al., 2005).    The 
apnoea protocol consisted of two minutes of calm and controlled breathing at a rate 
of 5-6 breaths per minute, followed by a deep, but not maximal inspiration before 
each apnoea. The apnoeas were conducted in a static sitting or lying position. The 
protocol mandated that apnoea training be performed for five out of seven days of 
each week. Participants in the  apnoeic group were supplied with a breath hold diary 
to record their longest breath hold time and fingertip pulse oximeter in order to 
monitor their oxygen desaturation, during apnoeas, and were instructed to interrupt 
their breath hold if their SpO2 levels fell to <60% as previously described  (Engan et 
al., 2013).  They were instructed to document their lowest SpO2 readings for each 
day of apnoea training whilst at SL. None of the participants in either group had 
received previous apnoea training prior to this study.  
Data collection and Measurements 
Baseline data was collected at effective SL (44m) 70 days prior to departure. 
Thereafter data collection was performed at 1400m, 2700m, 3400-3700m, 4050-
4200m, 4800m and 5100-5200m. 
HA-related symptoms were recorded twice daily using the updated 2018 Lake 
Louise Scoring (LLS) system (Roach et al., 2018). The total LLS score for an 
individual was calculated as the sum of the scores for the four symptoms (headache, 
nausea/vomiting, fatigue, and dizziness/light-headedness). AMS was defined as a 
total score of at least three points which included at least one score for headache at 
an altitude of >2000m and a recent height gain (Roach et al., 2018).  The subjects 
were advised not to take prophylactic acetazolamide. However, acetazolamide use 
was permitted, under medical guidance (by the expedition doctor) for the treatment 
of AMS.  The use of non-steroidal anti-inflammatory medication and paracetamol 
was permitted and documented. 
The Borg RPE was recorded at the end of each day (Borg 1970). This is a 15 point 
numerical scale numbered from 6-20, with values of 6 representing the resting state 
and 20, exhaustive exercise that has been used at HA previously (Borg 1970). The 
highest RPE during the day was recorded to reflect the overall effort.     The other 
physiological variables were recorded twice daily, pre breakfast and before evening 
meal and at least 3 hours after arrival at each new altitude. Blood pressure was 
measured on fully rested and seated subjects using a brachial cuff fitted to the 
dominant arm using the USCOM BP+ Device (Uscom, Sydney, NSW, Australia). 
Resting oxygen saturations (SpO2) at HA were measured from the finger at using a 
Nonin Onyx Series II pulse oximeter (Plymouth, MN 55441, USA). 
Sleep quality was examined daily using the Insomnia Severity Index (ISI) pre-
breakfast the night after arriving at each altitude  (Bastien et al., 2001). This is a 
short form questionnaire that was designed to assess the severity of both night-time 
and daytime components of insomnia. The ISI is a 7-item self-report questionnaire 
assessing the nature, severity, and impact of insomnia. The dimensions evaluated 
were the severity of sleep onset, sleep maintenance, early morning awakening 
problems, sleep dissatisfaction, interference of sleep difficulties with daytime 
functioning, noticeability of sleep problems by others, and distress caused by the 
sleep difficulties. A 5-point Likert scale was used to rate each item (e.g., 0 = no 
problem; 4 = very severe problem) to yield a total score ranging from 0 to 28. The 
total score was interpreted as follows: absence of insomnia (0–7); sub-threshold 
insomnia (8–14); moderate insomnia (15–21); and severe insomnia (>21) as 
previously described (Bastien et al., 2001). 
Anxiety levels were quantified using the Generalised Anxiety Disorder Assessment 
(GAD-7) questionnaire  (Spitzer et al., 2006) at sea level baseline and at 1400m (day 
1) and day 14 above 5000m. It is a seven-item instrument that is used to measure or
assess the severity of generalised anxiety disorder (GAD). Each item asks the 
individual to rate the severity of his or her symptoms over the past two weeks. The 
GAD-7 score is calculated by assigning scores of 0, 1, 2, and 3, to the response 
categories of “not at all”, “several days”, “more than half the days” and “nearly 
every day” respectively, and then adding together the scores for the seven questions 
with the total score ranging from 0 to 21. Total scores were used to determine the 
severity of anxiety symptoms which were graded as mild (score of 5-9),  moderate 
(10-14) and severe (15)  (Spitzer et al., 2006). 
Ethics 
The study was approved by the Ministry of Defence Research Ethics Committee and 
was conducted according to the standards of the Declaration of Helsinki.  All 
participants were required to provide written and informed consent prior to inclusion. 
Sample size and power calculation 
Our sample size was estimated from previously published work.  Schagatay et al 
(2005)  demonstrated a significant (p<0.001) and 18% reduction in splenic volume 
(due to splenic contraction) following three successive apneas among ten healthy 
adults. Gangwar et al (2019) demonstrated a significant reduction in AMS and 
higher SpO2 at HA among 40 healthy male adults randomized to IHE (n = 20; 12% 
FIO2 for 4 h per day for 4 consecutive days) versus non treatment (ie controls, 
n = 20). The participants were examined at SL and for seven consecutive days after 
being airlifted to 3520 m. We estimated that a similar sample size of at least 40 
participants, exposed to a longer period of self-administered IHE (six weeks) and 
to higher altitudes (hence more AMS symptoms) would provide sufficient power to 
detect notable differences in LLS and AMS prevalence among those randomised to 
IHE versus no IHE (controls). 
Statistical Analysis 
Data was analysed using GraphPad Prism version 6.07 (GraphPad Software, San 
Diego, CA, USA; www.graphpad.com) and SPSS version 22 (IBM®). Data inspection 
and the D'Agostino-Pearson normality test was undertaken to assess normality of all 
continuous data. Results are presented as mean ± standard deviation (SD). Categorical 
variables were compared using the Fishers exact and chi squared tests with 95% 
confidence intervals (CI). Independent two group comparisons of continuous data 
were analysed using an unpaired t-test or Mann Whitney test for parametric and non-
parametric data respectively. Comparisons of continuous data from >3 groups of 
parametric and non-parametric data were performed using a one-way ANOVA or 
Kruskal-Wallis test respectively. Correlation analyses were performed using Pearson 
Correlation and Spearman’s rank correlation with 95% CIs depending on data 
normality.  Only correlations with an R>0.20 were reported. A split level factorial 
ANOVA) was undertaken in SPSS to assess the main effects of apnoea training (yes 
or no), change in altitude, and potential interaction on the dependent outcomes. The 
normality of distribution, the homogeneity of covariance matrices and the 
independence and the sphericity assumptions were verified. Mauchly’s test was used 
to check for sphericity. If the sphericity assumption was violated, the Greenhouse-
Geisser correction was applied to adjust for the degrees of freedom of the interaction 
effect between different time points and different sample groups. If the value was less 
than 0.75, the Huynh-Feldt correction was used for repeated measures analysis of 
variance. Binary logistic regression was undertaken to identify the baseline factors that 
were predictive of AMS at HA. A p-value of <0.05 was considered significant for all 
comparisons. 
Results 
From the initial inclusion of 42 participants, two people from the control group were 
excluded: one lost their data collection booklets on the mountain and the other 
participant failed to complete their data collection. Hence, the final analysis cohort 
consisted of 40 participants which consisted of 19 in the apnoea group and 21 in the 
control group. Among the apnoea group eight completed the entire protocol without 
any missed sessions. Eleven participants missed one or more apnoea days as follows:  
<3 apnoea days (n=3), complete cessation after the first three weeks (n=4), missing 
up to a week in the middle (n=2), three weeks at end (n=2).  
The apnoea and control groups were very similar in terms of age, sex, ethnicity and 
other baseline demographics (Table 1). There was no difference in their baseline 
SpO2, heart rate, blood pressure, sleep and GAD-7 scores (Table 1). Apnoea training 
led to a significant improvement in longest breath-hold times from baseline 
(80.42±32.49 [median 87.00] seconds) to the end of week 6 (107.02±43.65 [median 
113.00] seconds; p=0.009). Their longest breath-hold time (134.94±56.04 seconds) 
significantly increased compared with their baseline values (p=0.0002).  
HA exposure led to a significant increase in resting heart rate, systolic and diastolic 
blood pressure, LLS (Figure 1), Borg and GAD-7 Scores and a reduction in SpO2 
(Figure 2) (Table 3). Out of the 40 subjects 28 had no significant anxiety symptoms 
(scores of 0-4), symptoms were mild in 8 (score 5-9) and at least moderate in 4 (Scores 
of >10) at Day 14 (5100m) There was no significant change in ISI scores.  
At HA, SpO2 inversely correlated with heart rate (r=-0.21; 95% CI -0.30 to -0.12: 
p<0.0001) and RPE (r=-0.60; -0.68 to -0.52: p<0.0001). GAD-7 scores correlated with 
RPE (r=0.29; 95% CI 0.06 to 0.48: p=0.01) and ISI scores (r=0.39; 0.18 to 0.56: 
p=0.0004). 
Overall 19 (47.5%) participants experienced AMS at one or more altitudes >2000m.  
There was no significant difference in the primary study outcome of AMS prevalence 
among the apnoea group (8/19=42.1%) versus controls (11/21=52.4%; RR 0.80; 95% 
CI 0.41 to 1.57: p=0.80). Eight participants from the apnoea group and six from the 
control group were treated with Acetazolamide (p=0.75). None of the measured SL 
variables were predictive of AMS at HA. Four participants from the apnoea group and 
four in the control group were treated with non-steroidal medication and/or 
paracetamol (p=1.0). 
Apnoea training (versus controls) also did not influence the secondary outcomes of 
GAD-7 scores (or prevalence of anxiety, GAD >5), ISI scores, RPE or other 
physiological measures including heart rate and SpO2. Furthermore, there was no 
evidence of an interaction of apnoea training-x-altitude on any of the main outcome 
variables. (Table 3)  
The eight participants who completed the full apnoea training protocol were again 
similar in demographics to the control group. Among this apnoea group the mean 
(±SD [range]) daily minimal SpO2 readings during apnoeas were significantly lower 
over week six (88.25±8.85% [61-98%]) versus week one (91.50±6.65% [74-99]; 
p=0.015). Conversely, their longest breath-hold times also significantly increased 
from baseline (82.77±34.96 [median 88.40] seconds) to the end of week six 
(109.58±55.12 [107.40] seconds) respectively (overall ANOVA p=0.009). On the 
split-level repeated measures ANOVA again there was no significant differences 
between this group (n=8) versus the control group on any of the main study outcomes 
or in the development of AMS. 
Discussion 
This is the first prospective randomised study to investigate the effects of apnoea 
training on the development of HA-related symptoms and AMS. In this study apnoea 
training was not associated with a reduction in AMS symptoms or severity. Apnoea 
training did not improve sleep quality, anxiety levels, RPE, resting heart rate, 
brachial blood pressure or SpO2.  
The premise of this study was based on published evidence over the last 15 years 
supporting a role for IHE to augment exercise performance across a wide range of 
sporting disciplines (Czuba et al., 2017). There is also emerging data to suggest that 
IHE can induce acclimation effects, with the potential to reduce HA-related illness 
(Gangwar et al., 2019; Muza 2007). This is an extremely exciting prospect given the 
enormous clinical burden of AMS, which is known to affect >40% of all persons 
travelling above 3500m (Bartsch and Swenson 2013; Boos et al., 2018). AMS 
remains the commonest medical condition encountered at HA and can rapidly 
progress to HACE and even death  (Bartsch and Swenson 2013). The underlying 
concept behind IHE is its utility to induce hypoxic preconditioning and lessen the 
deleterious effects of hypoxia.  Despite its promise, the published data is 
inconsistent. This may in part relate to the marked heterogeneity in the IHE protocols 
used in these studies. They have varied widely in terms of the hypoxic mode used 
(normobaric versus hypobaric hypoxia versus voluntary apnoea), its severity, 
duration (seconds to hours) and the number of cycles used  (Gangwar et al., 2019; 
Hamlin et al., 2018; Muza 2007). 
In our study we investigated whether apnoeic training, using voluntary breath holds, 
can deliver effective IHE and translate into better acclimatisation at HA and lessen 
HA-related symptoms (including AMS). Apnoeic training is proven to be effective in 
terms of improving free diving performance with some data to support its additional 
role in enhancing normoxic (ie sea level) athletic performance (Bain et al., 2018; 
Lemaitre et al., 2010).  The cited mechanisms for its performance enhancing effects 
include reducing blood acidosis, oxidative stress, basal metabolic and heart rate, 
increasing erythropoietin concentration and reticulocyte counts, enhanced splenic 
volume and contraction, lung volumes and anaerobic glycolysis activity as well 
improving cerebral blood flow, autonomic control and heart rate variability 
(Christoforidi et al., 2012; Engan et al., 2013; Inoue et al., 2013; Joulia et al., 2002; 
Lemaitre et al., 2010).  
Our desire to investigate the impact of apnoeic IHE on sleep and anxiety stems from 
our own previous work and that of others (Boos et al., 2018; Dong et al., 2013). We 
have recently observed that anxiety symptoms were independent predictors of AMS 
and its severity among a cohort of 80 healthy adults trekking to 5140m (Dong et al., 
2013). Anxiety-related symptoms are frequently exacerbated at HA and are strongly 
linked to both somatic symptoms and sleep quality (Dong et al., 2013). Indeed, we 
observed a significant increase in anxiety scores at HA versus SL in this study. There 
was significant, though modest, correlation between GAD-7 anxiety and ISI scores.  
Unfortunately, apnoeic training did not improve either of these scores. We had 
hypothesised that the controlled breathing which was integral to the apnoeic ‘warm 
up’ might have led to a degree of mindfulness and relaxation training that could have 
improved anxiety and sleep scores. It is worth noting that in this study the impact of 
HA on sleep quality was marginal and less than we might have anticipated which could 
reflect the gradual ascent profile used.  
There are many plausible reasons to explain the negative results of this study. 
Compliance with the apnoea protocol was poor and this, in itself, could have been 
sufficient to explain the lack of observed benefits. In our protocol apnoea training 
was conducted in five out of seven days in the week. Hence, the two rest days could 
have mitigated any acclimation effects. Consequently, we do not know whether a 
more intense apnoea protocol without rest days might have led to different results. 
Voluntary breath holding is uncomfortable and requires significant motivation. We 
did not include any encouragement methods to maintain compliance which is a 
limitation (van der Zwan et al., 2015). Another consideration is that the apnoea 
intensity was perhaps insufficient to achieve a decent hypoxic stimulus. In a very 
recently published study, Bouten et al observed that whilst eight weeks of apnoeic 
training (five apnoeas per day and similar to our protocol) led to an increase in 
splenic volume it was not sufficient to elicit significant training acclimation (Bouten 
et al., 2019). The mean daily lowest SpO2 recordings during week six of apnoeic 
training at SL in our study was certainly not insignificant at 88.25%. In fact, this is 
very similar to the average resting SpO2 recorded at 3400-3700m but may still be an 
insufficient stimulus  
Another factor that needs consideration regarding the modest hypoxia with breath 
hold training in this study is the limitations of peripheral pulse oximetry itself.  We 
used finger rather than central (e.g. earlobe) pulse oximetry to record SpO2 during 
breath-holds because of its ease of use, widespread use and to maintain consistency 
with SpO2 readings at HA.  However, there is a well-recognised time delay between 
the quantification of central hypoxia and its manifestation on peripheral pulse 
oximetry SpO2 readings (Lindholm et al., 2007; Pertzov et al., 2019). This  can lead 
to significant differences in simultaneously measured central oximetry readings 
which are reported to be  >6% lower with ear lobe versus finger readings (Lindholm 
et al., 2007). These differences may be even greater when the onset of hypoxia is 
rapid such as with breath-holding as in this study. Hence, it is possible that we have 
under appreciated the severity of induced hypoxia with apnoea training in this study. 
The hypoxic period in the majority of IHE studies, (using normobaric or hypobaric 
hypoxic training) have generally been well in excess of 30 minutes for each training 
session and far longer than the apnoeic period of <5  minutes obtained in our study  
(Gangwar et al., 2019; Lizamore and Hamlin 2017). Perhaps the potential hypoxic 
pre-conditioning effects of apnoea training are too short lived to induce a noticeable 
sustained pre-acclimatisation effect (Richardson et al., 2009).  Hypoxia is common 
to apnoeic training, IHE and HA exposure. However, with apnoea there is 
compensatory hypercapnoeic hypoxia whereas with IHE and genuine HA 
hypocapnoeic hyperventilation ensues; this leads to a progressive rise in end tidal O2 
and subsequent fall in end-tidal CO2 which is a crucial to HA acclimatization 
(Lizamore and Hamlin 2017; West J.B. 2012).  Hence, it is plausible that apnoea 
training may not increase chemoreceptor and carotid body sensitivity noted with 
traditional IHE, undermining some its acclimation potential.  
This study has a number of strengths that should be acknowledged. This was a 
prospective and randomised study conducted at both SL and HA.  Our sample size 
was larger than the majority of previously published apnoeic studies (Bouten et al., 
2019; Christoforidi et al., 2012; Engan et al., 2013; Richardson et al., 2009). Our 
study power was considerably strengthened by the fact the participants were 
investigated at seven different altitudes across a wide range of physiological and 
wellness outcomes (GAD-7 [anxiety], ISI [sleep quality], RPE [perceived exertion] 
and LLS [AMS symptoms]).   
Limitations 
The poor compliance rate with the apnoea protocol is a major limiting factor that 
needs to be re-emphasised, although the absence of benefit among those who 
completed the full apnoeic protocol strengthens the validity of our results. Whilst the 
overall altitudes and time of trekking were similar between the three groups studied, 
one of the groups (with a similar proportion randomised to apnoea and non-apnoea 
subjects) had a slightly different ascent profile and resided at higher altitude for a 
longer period. We did not examine comparative haemoglobin and erythropoietin 
levels in order to gauge the degree of successful hypoxic preconditioning with breath 
hold training. Whilst the longest breath hold duration significantly increased with 
apnoea training, the average breath hold duration was relatively short, again 
suggesting poor compliance with the protocol. Only the lowest SpO2 readings during 
apnoea were recorded. Finally, the ascent rate in this study was modest, particularly 
between 4800-5200m. This may have contributed to the relatively low incidence of 
AMS and limited the potential impact of breath-hold training on HA-related 
symptoms. 
Conclusion: 
In this study IHE using voluntary breath holds did not reduce the burden and severity 
AMS. Breath hold training also failed to provide any comparative advantages in terms 
of lessening the impact of HA exposure on sleep quality, anxiety scores, RPE during 
exercise, heart rate and blood pressure over traditional non-IHE preparation.  A larger 
study with a more aggressive protocol using compliance encouragement methods 
should be considered.    
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Height, cm 177.10±7.54 173.70±10.86 0.26 
Weight, kg 77.10±10.04 74.79±16.39 0.58 




















P values refer to comparison of control versus apnoea group at inclusion. 
Table 2 Comparative changes in Physiological indices and 
questionnaires with increasing high altitude 
Control  Apnoea  P value 












































































































































































All measured above relate to those measured on the first morning at each altitude except Borg 
Scores which were measured the on the evening before; P values refer to overall group 
comparisons of marginal means for the apnoea versus control groups; SpO2 oxygen saturation, 
%; SL, sea level; RPE, rating of perceived exertion 
Table 3 Results of Split-Level ANOVA on High altitude symptoms and 
Physiological measures  
Effect of Apnoea Effect of Altitude Interaction 
F P value F P value F P Value 
Heart rate 0.39 0.54 5.84 <0.0001 0.82 0.56 
Systolic blood pressure 2.65 0.12 4.59 <0.0001 1.08 0.38 
Diastolic blood pressure 1.76 0.20 5.29 <0.0001 0.41 0.18 
SpO2 3.33 0.08 138.47 <0.0001 1.34 0.24 
Borg RPE Scores 0.12 0.73 83.95 <0.0001 0.93 0.48 
Sleep scores 1.07 0.31 0.73 0.62 0.69 0.66 
GAD-7 0.90 0.35 5.46 0.006 1.45 0.24 
Lake Louise Scores 0.54 0.47 3.98 0.002 0.59 0.49 
All measured above relate to those measured on the first morning at each altitude except Borg Scores which were 
measured the on the evening before. SpO2 oxygen saturation, %; RPE, rating of perceived exertion; GAD, 
Generalised Anxiety Disorder 
Figures 
Figure 1 Comparative changes in Lake Louise Scores (mean ± standard error of the 
mean) with increase high altitude among the control versus apnoea groups 
Figure 2 Comparative changes in SpO2 (mean ± standard error of the mean) with 
increase high altitude among the control versus apnoea groups 
